Results 241 to 250 of about 1,504,803 (264)

THE EMPIRICAL ORIGIN OF DRUGS.

The Lancet, 1907
openaire   +1 more source

Efforts to control prescription drug abuse: Why clinicians should be concerned and take action as essential advocates for rational policy

Ca-A Cancer Journal for Clinicians, 2014
Aaron Gilson
exaly  

[Hematuria of drug origin].

La Revue du praticien, 1976
J P, Fillastre, G, Oksenhendler, J M, Kuhn, G, Landthaler   +3 more
openaire   +1 more source

Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

Advanced Drug Delivery Reviews, 2001
Per Artursson, Kristina Luthman
exaly  

[The origin of drugs].

Casopis ceskeho lekarnictva, 2004
openaire   +1 more source

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study

Lancet, The, 2007
Caroline Sabin, Jane Anderson, Chloe Orkin   +2 more
exaly  

[The dermatoses of drug origin].

Revue medicale de la Suisse romande, 1998
E, FRENK, C, MARCOLI
openaire   +1 more source

Determination of the Anticipated Therapeutic Effect of an Anticancer Drug in an Individual Patient

Ca-A Cancer Journal for Clinicians, 1964
R N Grant
exaly  

[The origins of drugs].

Soins; la revue de reference infirmiere, 1985
openaire   +1 more source

CANCER PATIENTS AT RISK OF DRUG INTERACTIONS

Ca-A Cancer Journal for Clinicians, 2007
exaly